510(k) Report

FDA applicant

Invitrogen Corporation

Grand Island2 decisions2002–20082 recalls

FDA records 2 decisions for Invitrogen Corporation (Grand Island) from 2002 to 2008: 1 510(k) clearance and 1 original PMA approval. Most are in product codes NYQ (Chromogenic In Situ Hybridization, Nucleic…) and NDS (Media, Culture, Ex Vivo, Tissue And Cell). Its devices cite 1 predicate, 0 of them its own earlier devices. 2 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, pathology panel, where it files most

How often FDA has decided Invitrogen Corporation’s devices, and how often a recall has named them.

FDA decisions per year

1in 2008

2008: 1
2007high 1 (2008) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

1in 2018

2011: 12018: 1
2007high 1 (2011) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Invitrogen Corporation by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Invitrogen Corporation’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report